Logo image of OXUR.BR

OXURION NV (OXUR.BR) Stock Price, Quote, News and Overview

EBR:OXUR - Euronext Brussels - BE0974487192 - Common Stock - Currency: EUR

0.074  -0.01 (-7.27%)

OXUR.BR Quote, Performance and Key Statistics

OXURION NV

EBR:OXUR (5/6/2025, 3:40:32 PM)

0.074

-0.01 (-7.27%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High1.37
52 Week Low0
Market Cap342.62K
Shares4.63M
Float3.71M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO07-07 2006-07-07


OXUR.BR short term performance overview.The bars show the price performance of OXUR.BR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

OXUR.BR long term performance overview.The bars show the price performance of OXUR.BR in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20K 40K 60K

The current stock price of OXUR.BR is 0.074 EUR. In the past month the price decreased by -36.54%. In the past year, price increased by 73900%.

OXURION NV / OXUR Daily stock chart

OXUR.BR Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 18.48 295.77B
1ABBV.MI ABBVIE INC 18.36 294.00B
AMG.DE AMGEN INC 13.11 129.04B
1GILD.MI GILEAD SCIENCES INC 13.7 116.36B
GIS.DE GILEAD SCIENCES INC 13.22 112.29B
VX1.DE VERTEX PHARMACEUTICALS INC 1501.35 100.35B
ARGX.BR ARGENX SE 370.33 34.60B
22UA.DE BIONTECH SE-ADR N/A 21.11B
IDP.DE BIOGEN INC 7.73 15.80B
1MRNA.MI MODERNA INC N/A 9.49B
0QF.DE MODERNA INC N/A 9.03B
BIO.DE BIOTEST AG 64.92 1.67B

About OXUR.BR

Company Profile

OXUR logo image Oxurion NV is a biopharmaceutical company, which engages in developing and commercializing medicines for the treatment of vitreo retinal diseases. The company is headquartered in Leuven (Louvain), Vlaams-Brabant and currently employs 11 full-time employees. The company went IPO on 2006-07-07. Its lead product, JETREA (ocriplasmin), has been approved by the United States Food and Drug Administration for the treatment of symptomatic vitreomacular adhesion (VMA) and was launched in January 2013. Oxurion partners with Alcon (Novartis) for the commercialization of JETREA outside the United States. In Europe, JETREA is approved for the treatment of vitreomacular traction (VMT), including when associated with macular hole of diameter less than or equal to 400 microns, which was launched in the United Kingdom and Germany. In addition, it also explores anti-PIGF (Placental Growth Factor), also referred to as TB-403, for the treatment of ophthalmic and oncology indications. The firm is active domestically, as well as operates through offices located in the United States and Ireland.

Company Info

OXURION NV

Gaston Geenslaan 1

LEUVEN (LOUVAIN) VLAAMS-BRABANT BE

Employees: 11

OXUR Company Website

OXUR Investor Relations

Phone: 3216751310

OXURION NV / OXUR.BR FAQ

What is the stock price of OXURION NV today?

The current stock price of OXUR.BR is 0.074 EUR. The price decreased by -7.27% in the last trading session.


What is the ticker symbol for OXURION NV stock?

The exchange symbol of OXURION NV is OXUR and it is listed on the Euronext Brussels exchange.


On which exchange is OXUR.BR stock listed?

OXUR.BR stock is listed on the Euronext Brussels exchange.


What is OXURION NV worth?

OXURION NV (OXUR.BR) has a market capitalization of 342.62K EUR. This makes OXUR.BR a Nano Cap stock.


How many employees does OXURION NV have?

OXURION NV (OXUR.BR) currently has 11 employees.


What are the support and resistance levels for OXURION NV (OXUR.BR) stock?

OXURION NV (OXUR.BR) has a resistance level at 0.09. Check the full technical report for a detailed analysis of OXUR.BR support and resistance levels.


Should I buy OXURION NV (OXUR.BR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does OXURION NV (OXUR.BR) stock pay dividends?

OXUR.BR does not pay a dividend.


What is the Price/Earnings (PE) ratio of OXURION NV (OXUR.BR)?

OXURION NV (OXUR.BR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.48).


OXUR.BR Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to OXUR.BR. When comparing the yearly performance of all stocks, OXUR.BR is one of the better performing stocks in the market, outperforming 99.98% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

OXUR.BR Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to OXUR.BR. OXUR.BR has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

OXUR.BR Financial Highlights

Over the last trailing twelve months OXUR.BR reported a non-GAAP Earnings per Share(EPS) of -1.48. The EPS increased by 99.36% compared to the year before.


Industry RankSector Rank
PM (TTM) 3966.67%
ROA 2.09%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%103.27%
Sales Q2Q%-97.59%
EPS 1Y (TTM)99.36%
Revenue 1Y (TTM)-98.86%

OXUR.BR Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 42% to OXUR.BR. The Buy consensus is the average rating of analysts ratings from 9 analysts.


Ownership
Inst Owners0.22%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts42.22
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A